Comparisons of cancer patients' survival and care in Europe up to 2007 show that although more patients are surviving for at least five years after diagnosis, there are large variations between countries, which are particularly ...
Sep 25, 2015
0
11
A University of Kentucky study shows that withaferin A, a component of Withania somnifera (winter cherry) plant extract, may hold promise as a new treatment for non-Hodgkin's lymphoma.
Sep 14, 2015
0
323
An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated ...
May 11, 2015
0
14
Referring patients with unexplained swollen neck glands for specialist investigations could help to avoid some of the thousands of deaths each year from lymphoma, a type of cancer.
Apr 27, 2015
1
33
A new study found that people with lower vitamin D levels prior to treatment for follicular lymphoma succumb to the disease or face relapse earlier than patients with sufficient vitamin D levels in their blood.
Mar 30, 2015
0
107
France's national cancer institute said on Tuesday there was a "clearly established link" between a rare form of cancer and a certain type of breast implant, as the health minister sought to allay fears.
Mar 17, 2015
0
7
A breakthrough in understanding of a rare form of blood cancer could lead to significant improvements in treatment for patients. Scientists from the University of Southampton announced their findings at a prestigious scientific ...
Dec 9, 2014
0
1
(Medical Xpress)—There have been 71 known cases worldwide of a type of blood cancer called anaplastic large cell lymphoma (ALCL) that the researchers suggest were associated with the patient's breast implants. This means ...
Sep 17, 2014
0
1
Each year, more than one thousand Norwegians develop lymphoma. A statistical genetic analysis can detect when the disease will be aggressive. Thereby, treatment can be initiated in time.
Aug 25, 2014
0
0
(HealthDay)—Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).
Jul 3, 2014
0
0
